Agios Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00847X1046
USD
27.42
0.44 (1.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
36.50
26.82
14.24
0.00
0.00
117.91
94.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
36.50
26.82
14.24
0.00
0.00
117.91
94.39
Raw Material Cost
9.82
9.50
20.26
18.78
18.77
17.94
8.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
156.78
119.90
111.68
111.91
106.12
123.50
106.97
Other Expenses
29.56
28.89
27.13
24.77
21.10
40.28
34.13
Total Expenditure (Excl Depreciation)
462.23
418.31
403.29
378.42
335.92
544.25
456.87
Operating Profit (PBDIT) excl Other Income
-425.7
-391.5
-389
-378.40000000000003
-335.90000000000003
-426.3
-362.5
Other Income
1,143.71
39.40
157.25
21.91
6.61
14.86
16.45
Operating Profit (PBDIT)
723.62
-345.47
-213.24
-337.73
-310.53
-394.85
-338.86
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
26.68
17.32
-6.02
-18.78
-18.77
99.98
85.82
Depreciation
5.65
6.62
18.56
18.78
18.77
16.62
7.17
Profit Before Tax
717.97
-352.09
-231.80
-356.51
-329.31
-411.47
-346.03
Tax
44.24
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
673.73
-352.09
-231.80
-356.51
-329.31
-411.47
-346.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
673.73
-352.09
-231.80
-356.51
-329.31
-411.47
-346.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
673.73
-352.09
-231.80
-356.51
-329.31
-411.47
-346.03
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,540.96
811.02
1,100.81
1,291.97
399.50
640.53
687.54
Earnings per share (EPS)
11.64
-6.33
-4.23
-6.36
-4.74
-6.86
-6.03
Diluted Earnings per share
11.64
-6.33
-4.23
-6.36
-4.74
-6.86
-6.03
Operating Profit Margin (Excl OI)
-1166.47%
-1459.52%
-2732.07%
0.0%
0.0%
-361.57%
-384.03%
Gross Profit Margin
1982.63%
-1287.94%
-1497.49%
0.0%
0.0%
-334.87%
-359.01%
PAT Margin
1845.92%
-1312.63%
-1627.82%
0.0%
0.0%
-348.97%
-366.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 36.19% vs 88.73% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 291.34% vs -51.90% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -9.15% vs -3.89% in Dec 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Agios Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
36.50
700.97
-664.47
-94.79%
Other Operating Income
0.00
0.00
0.00
Total Operating income
36.50
700.97
-664.47
-94.79%
Raw Material Cost
9.82
227.72
-217.90
-95.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
16.57
-16.57
-100.00%
Selling and Distribution Expenses
156.78
294.10
-137.32
-46.69%
Other Expenses
29.56
6.50
23.06
354.77%
Total Expenditure (Excl Depreciation)
462.23
603.39
-141.16
-23.39%
Operating Profit (PBDIT) excl Other Income
-425.74
97.57
-523.31
-536.34%
Other Income
1,143.71
19.32
1,124.39
5,819.82%
Operating Profit (PBDIT)
723.62
195.68
527.94
269.80%
Interest
0.00
16.57
-16.57
-100.00%
Exceptional Items
0.00
-163.43
163.43
100.00%
Gross Profit (PBDT)
26.68
473.25
-446.57
-94.36%
Depreciation
5.65
78.78
-73.13
-92.83%
Profit Before Tax
717.97
-63.11
781.08
1,237.65%
Tax
44.24
36.45
7.79
21.37%
Provisions and contingencies
0
0
0.00
Profit After Tax
673.73
-99.56
773.29
776.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
673.73
-99.56
773.29
776.71%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
673.73
-99.56
773.29
776.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,540.96
778.35
762.61
97.98%
Earnings per share (EPS)
11.64
-2.15
13.79
641.40%
Diluted Earnings per share
11.64
-2.15
13.79
641.40%
Operating Profit Margin (Excl OI)
-1,166.47%
13.92%
0.00
-1,180.39%
Gross Profit Margin
1,982.63%
2.24%
0.00
1,980.39%
PAT Margin
1,845.92%
-14.20%
0.00
1,860.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 36.19% vs 88.73% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 67.37 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 291.34% vs -51.90% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -42.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -9.15% vs -3.89% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1,166.47%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023